Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Novo Nordisk rebounds from 2024 lows as GLP-1 supply issues ease, partnerships expand, and valuation turns attractive. Find out why NVO stock is a buy.

The investment outlook has been uncertain thanks to factors like tariffs and trade wars, inflation concerns, a dispute ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

Drug services provider Medtide (3880.HK) is looking to raise HK$514 million (410 million yuan or $65.48 million) in a listing on the Hong Kong stock market, with plans to invest the proceeds into ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Today's supply chains are under constant pressure. Businesses face a growing number of challenges, such as rising raw ...

Read why the WEF predict that resilience, agility, and sustainability are key to operations and how supply chains will evolve ...

Prioritizing risk using structural simulation for complex global supply chains Disruptions in your supply chain can hurt your business, but not all disruptions are the same. Structural modeling offers ...

Third-party vendors are a well-known risk but they are often not the last point in the supply chain and cybersecurity leaders ...